NAD-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPγS binding in cloned 5-HT1A receptors

Journal of Receptors and Signal Transduction

Volumn 22, Issue 1-4, 2002, Pages 483-495

  Jerning, Eva ^a   Rosqvist, Susanne ^a   Mohell, Nina ^a,b  

^a ASTRAZENECA R AND D   (Sweden)

^b ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

5 HT1A antagonist; Receptor binding; 35S GTP S; 3H 8 OH DPAT; 3H NAD 299

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 CARBAMOYLTRYPTAMINE; BUSPIRONE; FLESINOXAN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); IPSAPIRONE; METITEPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; ROBALZOTAN; SEROTONIN; SEROTONIN 1A RECEPTOR; SPIPERONE; SULFUR 35;

ANIMAL CELL; BINDING AFFINITY; CONFERENCE PAPER; DRUG RECEPTOR BINDING; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BLOCKING;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0036978698     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1081/RRS-120014616     Document Type: Conference Paper

References (29)

1. Johansson, L.; Sohn, D.; Thorberg, S.-O.; Jackson, D.M.; Kelder, D.; Larsson, L.-G.; Rényi, L.; Ross, S.B.; Wallsten, C.; Eriksson, H.; Hu, P.-S.; Jerning, E.; Mohell, N.; Westlind-Danielsson, A. The Pharmacological Characterization of a Novel Selective 5-HydroxytryptaminelA Receptor Antagonist, NAD-299. J. Pharmacol. Exp. Ther. 1997, 283, 216-225.
2. 1A Receptor Antagonist, NAD-299, Reverses the SSRI-Induced Inhibition of Serotonergic Cell Firing in the Dorsal Raphe Nucleus in the Rat. European Neuropsychopharmacology 1998, 8 (2), 127.
3. 1A Receptor Antagonist NAD-299. European Neuropsychopharmacology 1998, 8 (2), 113.
4. 1A Autoreceptor Blockade Potentiates the Ability of the 5-HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5-HT In Vivo: A Microdialysis Study. J. Neurochem. 1993, 60, 776-779.
5. Blier, P.; de Montigny, C. Current Advances and Trends in the Treatment of Depression. Trends Pharmacol. Sci. 1994, 15, 220-226.
6. Artigas, F.; Perez, V.; Alvarez, E. Pindolol Induces a Rapid Improvement of Depressed Patients Treated with Serotonin Reuptake Inhibitors. Arch. Gen. Psychiatry 1994, 51, 248-251.
7. Blier, P.; Bergeron, R. Effectiveness of Pindolol with Selected Antidepressant Drugs in the Treatment of Major Depression. J. Clin. Psychopharmacol. 1995, 15, 217-222.
8. 1A) Receptors. Neuropsychopharmacology 1998, 18, 395-398.
9. 1A Receptor Antagonist. Eur. J. Pharmacol. 1998, 360, 219-225.
10. 1A Receptors Expressed in Chinese Hamster Ovary Cells. Biochem. Pharmacol. 1993, 45, 1003-1009.
11. Markwell, M.A.K.; Haas, S.M.; Bieber, L.L.; Tolbert, N.E. A Modification of the Lowry Procedure to Simplify Protein Determination in Membrane and Lipoprotein Samples. Anal. Biochem. 1978, 87, 206-210.
12. Lazareno, S.; Farries, T.; Birdsall, N.J.M. Pharmacological Characterization of Guanine Nucleotide Exchange Reactions in Membranes from CHO Cells Stably Transfected with Human Muscarinic Receptors ml-m4. Life Sci. 1993, 52, 449-456.
13. Munson, P.J.; Rodbard, D. Ligand: A Versatile Computerized Approach for Characterization of Ligand-Binding System. Anal. Biochem. 1980, 107, 220-239.
14. 3H]NAD-299. European Neuropsychopharmacology 1998, 8 (2), 100.
15. 35S]thio)Triphosphate Binding to Membranes from Human Neuroblastoma SH-SY5Y Cells. Mol. Pharmacol, 1995, 47, 848-854.
16. Emmerson, P.J.; Clark, M.J.; Mansour, A.; Akil, H.; Woods, J.H.; Medzihradsky, E Characterization of Opioid Agonist Efficacy in a C6 Glioma Cell Line Expressing the Mu Opioid Receptor. J. Pharmacol. Exp. Ther. 1996, 278, 1121-1127.
17. Lorenzen, A.; Guerra, L.; Vogt, H.; Schwabe, U. Interaction of Full and Partial Agonists of the A1 Adenosine Receptor with Receptor/G Protein Complexes in Rat Brain Membranes. Mol. Pharmacol. 1996, 49, 915-926.
18. Selley, D.E.; Sim, L.J.; Xiao, R.; Liu, Q.; Childers, S.R. Mu-Opioid Receptor-Stimulated Guanosine-5′-O-(Gamma-Thio)-Triphosphate Binding in Rat Thalamus and Cultured Cell Lines: Signal Transduction Mechanisms Underlying Agonist Efficacy. Mol. Pharmacol. 1997, 51, 87-96.
19. 35S] Binding. J. Pharmacol. Exp. Ther. 1998, 285, 119-126.
20. 1B Agonists: A Comparative Study with Dorsal Raphe Neurons. Neuropharmacology 1988, 27, 707-715.
21. Yocca, F.D.; Iben, L.; Meller, E. Lack of Apparent Receptor Reserve at Postsynaptic 5-Hydroxytryptaminela Receptors Negatively Coupled to Adenylyl Cyclase Activity in Rat Hippocampal Membranes. Mol. Pharmacol. 1992, 41, 1066-1072.
22. Meller, E.; Goldstein, M.; Bohmaker, K. Receptor Reserve for 5-HydroxytryptaminelA-Mediated Inhibition of Serotonin Synthesis: Possible Relationship to Anxiolytic Properties of 5-HydroxytryptaminelA Agonists. Mol. Pharmacol. 1990, 37, 231-237.
23. 1A Receptors as a Function of Receptors as a Function of Receptor: G-Protein Stoichiometry. Neuropharmacology 1997, 36, 451-459.
24. 35S]GTP_S Binding. Eur. J. Pharmacol. 1997, 320, 267-275.
25. De Lean, A.; Stadel, J.M.; Lefkowitz, R.J. A Ternary Complex Model Explains the Agonist-Specific Binding Properties of the Adenylate Cyclase-Coupled β-Adrenergic Receptor. J. Biol. Chem. 1980, 255, 7108-7117.
26. Kent, R.S.; De Lean, A.; Lefkowitz, R.J. A Quantitative Analysis of Beta-Adrenergic Receptor Interactions: Resolution of High and Low Affinity States of the Receptor by Computer Modeling of Ligand Binding Data. Mol. Pharmacol. 1980, 17, 14-23.
27. 2 Receptor. Eur. J. Pharmacol. 1998, 346, 299-307.
28. Freedman, S.B.; Harley, E.A.; Iversen, L.L. Relative Affinities of Drugs Acting at Cholinoceptors in Displacing Agonist and Antagonist Radioligands: The Nms/Oxo-M Ratio as an Index of Efficacy at Cortical Muscarinic Receptors. Br. J. Pharmacol. 1988, 93, 437-445.
29. 2 Guanine Nucleotide-Binding Protein-Coupled Receptor: Utilization of Receptor State Binding Affinities. Mol. Pharmacol. 1992, 42, 432-438.